Form D · Biotechnology

VelosBio Inc.

Belmont, CA · CIK 0001732599

Offering snapshot reported Jul 14, 2020 · SEC filing

Reported sold
$137M
Offering amount: $137M
Investors reported
38
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 7, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 14, 2020Initial$137,000,002No comparison38SEC filing
May 11, 2020Amendment$59,305,204$24,003,959vs Oct 10, 201838SEC filing
Oct 10, 2018Initial$35,301,245No comparison20SEC filing
Jul 30, 2018Initial$6,480,000No comparison2SEC filing
Feb 26, 2018Initial$7,700,000No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-370879

Source: Form D, filed Jul 14, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Chin Director
Alan Colowick Director
Min Cui Director
Cam Gallagher Director
Scott L. Glenn Director
David Johnson Director, Executive
Scott Karchmer Executive
Clayton Knox Executive
Langdon Miller Executive
Jayson Punwani Director
Karan Takhar Director
Jonathan Tobin Director
Richard Vincent Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1025 Alameda De Las Pulgas No. 634
Belmont, CA, 94002